Association of TP53 polymorphisms with primary open-angle glaucoma: A meta-analysis

Investigative Ophthalmology and Visual Science

Volumn 53, Issue 7, 2012, Pages 3756-3763

  Guo, Yatu ^a,b,c   Zhang, Hongtuan ^d   Chen, Xia ^a   Yang, Xiong ^d   Cheng, Wenbo ^a,e   Zhao, Kanxing ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b TIANJIN EYE HOSPITAL   (China)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d SECOND HOSPITAL OF TIANJIN MEDICAL UNIVERSITY   (China)

^e Neurology Department Changzhi City People s Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ARTICLE; ASIAN; CAUCASIAN; ETHNICITY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INTRON; META ANALYSIS; OPEN ANGLE GLAUCOMA; PRIORITY JOURNAL; RISK; SYSTEMATIC REVIEW; ETHNOLOGY; GENETICS; REVIEW; RISK FACTOR; TUMOR SUPPRESSOR GENE;

ASIAN CONTINENTAL ANCESTRY GROUP; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; GENES, P53; GLAUCOMA, OPEN-ANGLE; HUMANS; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 84865846095     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.12-9818     Document Type: Article

References (51)

1. Sharts-Hopko NC, Glynn-Milley C. Primary open-angle glaucoma. Am J Nurs. 2009;109:40-47; quiz 48.
2. Coleman AL, Brigatti L. The glaucomas. Minerva Med. 2001; 92:365-379.
3. Cedrone C, Mancino R, Cerulli A, Cesareo M, Nucci C. Epidemiology of primary glaucoma: prevalence, incidence, and blinding effects. Prog Brain Res. 2008;173:3-14.
4. Rouland JF, Berdeaux G, Lafuma A. The economic burden of glaucoma and ocular hypertension: implications for patient management: a review. Drugs Aging. 2005;22:315-321.
5. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90:262-267.
6. Bonovas S, Peponis V, Filioussi K. Diabetes mellitus as a risk factor for primary open-angle glaucoma: a meta-analysis. Diabet Med. 2004;21:609-614.
7. Bron A, Chaine G, Villain M, et al. Risk factors for primary open-angle glaucoma [in French]. J Fr Ophtalmol. 2008;31: 435-444.
8. Ozcura F, Aydin S. Is diabetes mellitus a risk factor or a protector for primary open angle glaucoma? Med Hypotheses. 2007;69:233-234.
9. Zanon-Moreno V, Garcia-Medina JJ, Zanon-Viguer V, Moreno- Nadal MA, Pinazo-Duran MD. Smoking, an additional risk factor in elder women with primary open-angle glaucoma. Mol Vis. 2009;15:2953-2959.
10. Charliat G, Jolly D, Blanchard F. Genetic risk factor in primary open-angle glaucoma: a case-control study. Ophthalmic Epidemiol. 1994;1:131-138.
11. Fan BJ, Wang DY, Lam DS, Pang CP. Gene mapping for primary open angle glaucoma. Clin Biochem. 2006;39:249-258.
12. Fingert JH. Primary open-angle glaucoma genes. Eye. 2011;25: 587-595.
13. Liu Y, Allingham RR. Molecular genetics in glaucoma. Exp Eye Res. 2011;93:331-339.
14. van Koolwijk LM, Despriet DD, van Duijn CM, et al. Genetic contributions to glaucoma: heritability of intraocular pressure, retinal nerve fiber layer thickness, and optic disc morphology. Invest Ophthalmol Vis Sci. 2007;48:3669-3676.
15. Bergen AA, Leschot NJ, Hulsman CA, De Smet MD, De Jong PT. From gene to disease; primary open-angle glaucoma and three known genes: MYOC, CYP1B1 and OPTN [in Dutch]. Ned Tijdschr Geneeskd. 2004;148:1343-1344.
16. Fingert JH, Heon E, Liebmann JM, et al. Analysis of myocilin mutations in 1703 glaucoma patients from five different populations. Hum Mol Genet. 1999;8:899-905.
17. Pasutto F, Mardin CY, Michels-Rautenstrauss K, et al. Profiling of WDR36 missense variants in German patients with glaucoma. Invest Ophthalmol Vis Sci. 2008;49:270-274.
18. Rezaie T, Child A, Hitchings R, et al. Adult-onset primary openangle glaucoma caused by mutations in optineurin. Science. 2002;295:1077-1079.
19. Fingert JH, Honkanen RA, Shankar SP, et al. Familial cavitary optic disk anomalies: identification of a novel genetic locus. Am J Ophthalmol. 2007;143:795-800.
20. Markandaya M, Ramesh TK, Selvaraju V, et al. Genetic analysis of an Indian family with members affected with juvenile-onset primary open-angle glaucoma. Ophthalmic Genet. 2004;25: 11-23.
21. Fernandez-Martinez L, Letteboer S, Mardin CY, et al. Evidence for RPGRIP1 gene as risk factor for primary open angle glaucoma. Eur J Hum Genet. 2011;19:445-451.
22. Junemann AG, von Ahsen N, Reulbach U, et al. C677T variant in the methylentetrahydrofolate reductase gene is a genetic risk factor for primary open-angle glaucoma. Am J Ophthalmol. 2005;139:721-723.
23. Wirtz MK, Samples JR, Kramer PL, et al. Mapping a gene for adult-onset primary open-angle glaucoma to chromosome 3q. Am J Hum Genet. 1997;60:296-304.
24. Monemi S, Spaeth G, DaSilva A, et al. Identification of a novel adult-onset primary open-angle glaucoma (POAG) gene on 5q22.1. Hum Mol Genet. 2005;14:725-733.
25. Juronen E, Tasa G, Veromann S, et al. Polymorphic glutathione S-transferase M1 is a risk factor of primary open-angle glaucoma among Estonians. Exp Eye Res. 2000;71:447-452.
26. Wirtz MK, Samples JR, Rust K, et al. GLC1F, a new primary open-angle glaucoma locus, maps to 7q35-q36. Arch Ophthalmol. 1999;117:237-241.
27. Trifan OC, Traboulsi EI, Stoilova D, et al. A third locus (GLC1D) for adult-onset primary open-angle glaucoma maps to the 8q23 region. Am J Ophthalmol. 1998;126:17-28.
28. Sarfarazi M, Child A, Stoilova D, et al. Localization of the fourth locus (GLC1E) for adult-onset primary open-angle glaucoma to the 10p15-p14 region. Am J Hum Genet. 1998;62:641-652.
29. Matlashewski G, Lamb P, Pim D, Peacock J, Crawford L, Benchimol S. Isolation and characterization of a human p53 cDNA clone: expression of the human p53 gene. EMBO J. 1984;3:3257-3262.
30. Isobe M, Emanuel BS, Givol D, Oren M, Croce CM. Localization of gene for human p53 tumour antigen to band 17p13. Nature. 1986;320:84-85.
31. Sager R. Tumor suppressor genes: the puzzle and the promise. Science. 1989;246:1406-1412.
32. Morrison RS, Kinoshita Y, Johnson MD, Guo W, Garden GA. p53-dependent cell death signaling in neurons. Neurochem Res. 2003;28:15-27.
33. Lane DP. Cancer. p53, guardian of the genome. Nature. 1992; 358:15-16.
34. Xu H, el-Gewely MR. P53-responsive genes and the potential for cancer diagnostics and therapeutics development. Biotechnol Annu Rev. 2001;7:131-164.
35. Izzotti A, Di Marco B, De Flora S, Sacca S. Open angle glaucoma: epidemiology, pathogenesis and prevention [in Italian]. Recenti Prog Med. 2006;97:37-45.
36. Quigley HA, Nickells RW, Kerrigan LA, Pease ME, Thibault DJ, Zack DJ. Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest Ophthalmol Vis Sci. 1995;36:774-786.
37. Lin HJ, Chen WC, Tsai FJ, Tsai SW. Distributions of p53 codon 72 polymorphism in primary open angle glaucoma. Br J Ophthalmol. 2002;86:767-770.
38. Acharya M, Mitra S, Mukhopadhyay A, Khan M, Roychoudhury S, Ray K. Distribution of p53 codon 72 polymorphism in Indian primary open angle glaucoma patients. Mol Vis. 2002;8: 367-371.
39. Blanco-Marchite C, Sanchez-Sanchez F, Lopez-Garrido MP, et al. WDR36 and P53 gene variants and susceptibility to primary open-angle glaucoma: analysis of gene-gene interactions. Invest Ophthalmol Vis Sci. 2011;52:8467-8478.
40. Daugherty CL, Curtis H, Realini T, Charlton JF, Zareparsi S. Primary open angle glaucoma in a Caucasian population is associated with the p53 codon 72 polymorphism. Mol Vis. 2009;15:1939-1944.
41. Dimasi DP, Hewitt AW, Green CM, Mackey DA, Craig JE. Lack of association of p53 polymorphisms and haplotypes in high and normal tension open angle glaucoma. J Med Genet. 2005; 42:e55.
42. Mabuchi F, Sakurada Y, Kashiwagi K, Yamagata Z, Iijima H, Tsukahara S. Lack of association between p53 gene polymorphisms and primary open angle glaucoma in the Japanese population. Mol Vis. 2009;15:1045-1049.
43. Saglar E, Yucel D, Bozkurt B, Ozgul RK, Irkec M, Ogus A. Association of polymorphisms in APOE, p53, and p21 with primary open-angle glaucoma in Turkish patients. Mol Vis. 2009;15:1270-1276.
44. Silva RE, Arruda JT, Rodrigues FW, Moura KK. Primary open angle glaucoma was not found to be associated with p53 codon 72 polymorphism in a Brazilian cohort. Genet Mol Res. 2009;8:268-272.
45. Fan BJ, Liu K, Wang DY, et al. Association of polymorphisms of tumor necrosis factor and tumor protein p53 with primary open-angle glaucoma. Invest Ophthalmol Vis Sci. 2010;51: 4110-4116.
46. Worley A, Grimmer-Somers K. Risk factors for glaucoma: what do they really mean? Aust J Prim Health. 2011;17:233-239.
47. Khan AO. Genetics of primary glaucoma. Curr Opin Ophthalmol. 2011;22:347-355.
48. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell. 1997;88:323-331.
49. Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG. Replication validity of genetic association studies. Nat Genet. 2001;29:306-309.
50. Munafo M. Replication validity of genetic association studies of smoking behavior: what can meta-analytic techniques offer? Nicotine Tob Res. 2004;6:381-382.
51. Attia J, Thakkinstian A, D'Este C. Meta-analyses of molecular association studies: methodologic lessons for genetic epidemiology. J Clin Epidemiol. 2003;56:297-303.